Immunosenescence and novel vaccination strategies for the elderly. - Wikidata - wikimedia - TriplyDB

Immunosenescence and novel vaccination strategies for the elderly.

Immunosenescence and novel vaccination strategies for the elderly.

http://www.wikidata.org/entity/Q36962721

about

The anti-aging effects of LW-AFC via correcting immune dysfunctions in senescence accelerated mouse resistant 1 (SAMR1) strain Vaccines for Acinetobacter baumannii: thinking "out of the box".Improvement in Th1/Th2 immune homeostasis, antioxidative status and resistance to pathogenic E. coli on consumption of probiotic Lactobacillus rhamnosus fermented milk in aging mice The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 Ligand.Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.Identification of immunogenic MAGED4B peptides for vaccine development in oral cancer immunotherapy Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens Income and Markers of Immunological Cellular Aging.The aged lymphoid tissue environment fails to support naïve T cell homeostasis Modulation of Primary Immune Response by Different Vaccine Adjuvants.Enhanced Viral Replication by Cellular Replicative Senescence.Towards Vaccine 3.0: new era opened in vaccine research and industry.Arguing the misconceptions in allergen-specific immunotherapy.Vaccination in the elderly: what can be recommended?Changing face of vaccination in immunocompromised hosts.The herpes zoster subunit vaccine.Mechanisms Underlying T Cell Immunosenescence: Aging and Cytomegalovirus Infection.Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.Vaccine profile of herpes zoster (HZ/su) subunit vaccine.Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges.Role of Dendritic Cells in Inflammation and Loss of Tolerance in the Elderly.Challenges in adult vaccination.Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics.

P2860

Q30819335-4BFE8108-0942-41B9-B139-A16FE3AECC59 Q33637895-AEB085DC-3BD5-418B-8711-2FCD480D85CD Q34116089-40ECBFD3-30D9-40EA-B6F8-042CC758A6F0 Q35225020-06917541-471F-4D90-B772-AE13A9380436 Q35810437-1B010E7A-70D2-426B-A5E9-26276FE02F5F Q35887112-B7177CB4-89E0-49CF-A588-83D0305CAB11 Q35896241-E7300E0E-16B3-4A8F-9FB0-A87D83335301 Q36500269-C748296C-BF7F-4C48-9372-6C1BC16C875A Q37053013-59A99AAC-F4E6-4A84-B193-5B8B9A9F1C68 Q37144571-F7FEECB6-C37E-4AB4-BFB6-BE4F4CE3DD9E Q37342800-F8C92312-2FD7-4791-94C3-1655B3C0D95F Q37378491-950AF188-3348-405C-858E-373BF9AC092E Q37473508-805BB855-E740-4DCA-A8DD-AB1EFE184669 Q38217592-24F1958A-4F64-4C5F-8E01-B4A3A17217C3 Q38220158-D5A95E5A-C6C3-49B7-92CF-DD3D5DCE5E4C Q38225998-CACF2AAC-4C50-4869-9A5C-345CD55C30C0 Q38728931-DCF00935-1402-4522-9A7F-FB0CC344EF03 Q39023427-239CC36D-9DE6-45D3-80AA-BC3FE5BD025A Q39043124-E1228D63-753E-4269-9F51-5653981A9D50 Q40208840-5EC9EE1E-12BC-42C5-8112-0DAFA02A3327 Q40778022-3C2E5D9E-4F7E-4EAC-B551-F20C157D54BA Q41123306-C1777B27-6524-4528-85B5-BE251B7B4EB5 Q51773551-AB95CD08-F508-4918-9EA5-F03547C5733E Q55424061-3494DF94-35E1-4463-BFB8-1B8D78151AB1

P2860

Immunosenescence and novel vaccination strategies for the elderly.

http://www.wikidata.org/entity/Q36962721

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Immunosenescence and novel vaccination strategies for the elderly.

@en

type

label

Immunosenescence and novel vaccination strategies for the elderly.

@en

prefLabel

Immunosenescence and novel vaccination strategies for the elderly.

@en

P1433

Q36962721-0DDEDF8F-0304-44FC-905A-0736CD254924

P1476

Q36962721-92D8E13C-97A4-4233-A4DC-CE3694A4168E

P2093

Q36962721-D967B335-3355-424D-98F2-63B6873C76BD

P2860

Q36962721-06C2E7FA-9836-4660-8314-ACC7BBEEE2A1

Q36962721-0D9394CB-FAE5-478D-B9A2-2A113B06B091

Q36962721-124E5FBE-9382-4027-A8FD-2C71A57A1D70

Q36962721-15990249-AA13-473F-8A59-57FFF2154B58

Q36962721-16C68831-9AC4-4C73-8362-27F5448BCC11

Q36962721-1D7D0AAC-C424-46E5-BDC0-89518B3327EB

Q36962721-2441B837-CE94-409C-BF9C-3C430B8B1359

Q36962721-24D7907C-67E9-4AEE-9088-288F16379EBB

Q36962721-26B60806-60EE-4A55-BD2B-2E9127EF30BA

Q36962721-284FDEBB-66E8-4EED-95A0-3CBE5D84146D

P304

Q36962721-17E06461-6A94-4BF0-A71D-85086CC7391F

P31

Q36962721-401D8532-F68E-4113-BFEB-9D92F10C6A0C

P356

Q36962721-351C0828-E0E7-44C9-B026-FD263894AF23

P478

Q36962721-E92F65F4-11D4-4FC0-AB7A-5AE9689FE6B9

P50

Q36962721-618B11A1-437E-4886-B09E-EF8729BE27C0

P577

Q36962721-0BC500B7-3A88-498F-BF4F-BBF4C943ADC4

P5875

Q36962721-7E05CFBD-C6E4-419B-B8D1-472E4DA60BE9

P698

Q36962721-22B351F4-A2F5-4DC5-A013-F95238404FD4

P932

Q36962721-CB2E5563-E0A4-48E6-B8DD-C64A722FC3BD

P356

FIMMU.2013.00171

P1433

Frontiers in Immunology

P1476

Immunosenescence and novel vaccination strategies for the elderly

@en

P2093

Michael G Dorrington

http://www.w3.org/2001/XMLSchema#string

P2860

Matrix-M™ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Influenza vaccination for healthcare workers who work with the elderly

Vaccines for preventing pneumococcal infection in adults

Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses

The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Effects of school closure on incidence of pandemic influenza in Alberta, Canada.

P304

171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2013.00171

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

245029792

http://www.w3.org/2001/XMLSchema#string

P698

23825474

http://www.w3.org/2001/XMLSchema#string

P932

3695377

http://www.w3.org/2001/XMLSchema#string